about
Human endogenous retroviruses and the nervous systemReassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosisOptimization of a high-throughput whole blood expression profiling methodology and its application to assess the pharmacodynamics of interferon (IFN) beta-1a or polyethylene glycol-conjugated IFN beta-1a in healthy clinical trial subjects.Association of CD58 Polymorphism with Multiple Sclerosis and Response to Interferon ß Therapy in A Subset of Iranian PopulationInterferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis.Determinants of interferon β efficacy in patients with multiple sclerosis.Risk conferring genes in multiple sclerosis.Pharmacogenomics and multiple sclerosis: moving toward individualized medicine.Participatory medicine and patient empowerment towards personalized healthcare in multiple sclerosis.Association between upstream purine complexes of human caveolin-1 gene and schizophrenia in qazvin province of iran.miR-145 and miR20a-5p Potentially Mediate Pleiotropic Effects of Interferon-Beta Through Mitogen-Activated Protein Kinase Signaling Pathway in Multiple Sclerosis Patients.
P2860
Q27012467-D1D14F45-452C-4841-B3F3-9DC36AFF99FCQ28740839-BA81560E-9C00-477F-84A2-429CEB3CA0B7Q34536940-CD70DF8E-7250-4694-8ED5-389BAF263509Q34979385-9B6788BF-E1DB-47A6-94FC-F6CDE17E7F5EQ37221728-89167033-345D-479D-BCA8-9A3A7A3413FCQ37848651-3ECD6105-5884-4FF9-8ABF-BB4331E75A19Q37857943-7082E531-9452-40EB-A36E-67CD36C0E20FQ37893991-C1FE2BD9-2A43-4587-BAC3-23432B7A7BE4Q37987991-030C30EE-E246-4578-BB9B-8D014F18E383Q42123055-5CA4898D-2259-4FA9-844B-8A8651376CCCQ51381933-DBA4572A-9AA5-4720-B911-48A80BC628DE
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IFN-beta pharmacogenomics in multiple sclerosis.
@en
IFN-beta pharmacogenomics in multiple sclerosis.
@nl
type
label
IFN-beta pharmacogenomics in multiple sclerosis.
@en
IFN-beta pharmacogenomics in multiple sclerosis.
@nl
prefLabel
IFN-beta pharmacogenomics in multiple sclerosis.
@en
IFN-beta pharmacogenomics in multiple sclerosis.
@nl
P2093
P2860
P356
P1433
P1476
IFN-beta pharmacogenomics in multiple sclerosis.
@en
P2093
Elena Urcelay
Koen Vandenbroeck
Manuel Comabella
P2860
P304
P356
10.2217/PGS.10.108
P577
2010-08-01T00:00:00Z